logo
Trump's ‘Gold Standard' for Science Manufactures Doubt

Trump's ‘Gold Standard' for Science Manufactures Doubt

The Atlantic20-07-2025
Late last month, the White House Office of Science and Technology Policy released a document detailing its vision for scientific integrity. Its nine tenets, first laid out in President Donald Trump's executive order for ' Restoring Gold Standard Science,' seem anodyne enough: They include calls for federal and federally supported science to be reproducible and transparent, communicative of error and uncertainty, and subject to unbiased peer review. Some of the tenets might be difficult to apply in practice—one can't simply reproduce the results of studies on the health effects of climate disasters, for example, and funding is rarely available to replicate expensive studies. But these unremarkable principles hide a dramatic shift in the relationship between science and government.
Trump's executive order promises to ensure that 'federal decisions are informed by the most credible, reliable, and impartial scientific evidence available.' In practice, however, it gives political appointees—most of whom are not scientists—the authority to define scientific integrity and then decide which evidence counts and how it should be interpreted. The president has said that these measures are necessary to restore trust in the nation's scientific enterprise— which has indeed eroded since the last time he was in office. But these changes will likely only undermine trust further. Political officials no longer need to rigorously disprove existing findings; they can cast doubt on inconvenient evidence, or demand unattainable levels of certainty, to make those conclusions appear unsettled or unreliable.
In this way, the executive order opens the door to reshaping science to fit policy goals rather than allowing policy to be guided by the best available evidence. Its tactics echo the 'doubt science' pioneered by the tobacco industry, which enabled cigarette manufacturers to market a deadly product for decades. But the tobacco industry could only have dreamed of having the immense power of the federal government. Applied to government, these tactics are ushering this country into a new era of doubt in science and enabling political appointees to block any regulatory action they want to, whether it's approving a new drug or limiting harmful pollutants.
Historically, political appointees generally—though not always—deferred to career government scientists when assessing and reporting on the scientific evidence underlying policy decisions. But during Trump's first term, these norms began to break down, and political officials asserted far greater control over all facets of science-intensive policy making, particularly in contentious areas such as climate science. In response, the Biden administration invested considerable effort in restoring scientific integrity and independence, building new procedures and frameworks to bolster the role of career scientists in federal decision making.
Trump's new executive order not only rescinds these Joe Biden–era reforms but also reconceptualizes the meaning of scientific integrity. Under the Biden-era framework, for example, the definition of scientific integrity focused on 'professional practices, ethical behavior, and the principles of honesty and objectivity when conducting, managing, using the results of, and communicating about science and scientific activities.' The framework also emphasized transparency, and political appointees and career staff were both required to uphold these scientific standards. Now the Trump administration has scrapped that process, and appointees enjoy full control over what scientific integrity means and how agencies review and synthesize scientific literature necessary to support and shape policy decisions.
Although not perfect, the Biden framework also included a way for scientists to appeal decisions by their supervisors. By contrast, Trump's executive order creates a mechanism by which career scientists who publicly dissent from the pronouncements of political appointees can be charged with 'scientific misconduct' and be subject to disciplinary action. The order says such misconduct does not include differences of opinion, but gives political appointees the power to determine what counts, while providing employees no route for appeal. This dovetails with other proposals by the administration to make it easier to fire career employees who express inconvenient scientific judgments.
When reached for comment, White House spokesperson Kush Desai argued that 'public perception of scientific integrity completely eroded during the COVID era, when Democrats and the Biden administration consistently invoked an unimpeachable 'the science' to justify and shut down any reasonable questioning of unscientific lockdowns, school shutdowns, and various intrusive mandates' and that the administration is now 'rectifying the American people's complete lack of trust of this politicized scientific establishment.'
But the reality is that, armed with this new executive order, officials can now fill the administrative record with caveats, uncertainties, and methodological limitations—regardless of their relevance or significance, and often regardless of whether they could ever realistically be resolved. This strategy is especially powerful against standards enacted under a statute that takes a precautionary approach in the face of limited scientific evidence.
Some of our most important protections have been implemented while acknowledging scientific uncertainty. In 1978, although industry groups objected that uncertainty was still too high to justify regulations, several agencies banned the use of chlorofluorocarbons (CFCs) as propellants in aerosol spray cans, based on modeling that predicted CFCs were destroying the ozone layer. The results of the modeling were eventually confirmed, and the scientists who did the work were awarded the 1995 Nobel Prize in Chemistry.
Elevating scientific uncertainty above other values gives political appointees a new tool to roll back public-health and environmental standards and to justify regulatory inaction. The result is a scientific record created less to inform sound decision making than to delay it—giving priority to what we don't know over what we do. Certainly, probing weaknesses in scientific findings is central to the scientific enterprise, and good science should look squarely at ways in which accepted truths might be wrong. But manufacturing and magnifying doubt undercuts science's ability to describe reality with precision and fealty, and undermines legislation that directs agencies to err on the side of protecting health and the environment. In this way, the Trump administration can effectively violate statutory requirements by stealth, undermining Congress's mandate for precaution by manipulating the scientific record to appear more uncertain than scientists believe it is.
An example helps bring these dynamics into sharper focus. In recent years, numerous studies have linked PFAS compounds —known as 'forever chemicals' because they break down extremely slowly, if at all, in the environment and in human bodies—to a range of health problems, including immunologic and reproductive effects; developmental effects or delays in children, including low birth weight, accelerated puberty, and behavioral changes; and increased risk of prostate, kidney, and testicular cancers.
Yet despite promises from EPA Administrator Lee Zeldin to better protect the public from PFAS compounds, efforts to weaken current protections are already under way. The president has installed in a key position at the EPA a former chemical-industry executive who, in the first Trump administration, helped make regulating PFAS compounds more difficult. After industry objected to rules issued by the Biden administration, Trump's EPA announced that it is delaying enforcement of drinking-water standards for two of the PFAS forever chemicals until 2031 and rescinding the standards for four others. But Zeldin faces a major hurdle in accomplishing this feat: The existing PFAS standards are backed by the best currently available scientific evidence linking these specific chemicals to a range of adverse health effects.
Here, the executive order provides exactly the tools needed to rewrite the scientific basis for such a decision. First, political officials can redefine what counts as valid science by establishing their own version of the 'gold standard.' Appointees can instruct government scientists to comb through the revised body of evidence and highlight every disagreement or limitation—regardless of its relevance or scientific weight. They can cherry-pick the data, giving greater weight to studies that support a favored result. Emphasizing uncertainty biases the government toward inaction: The evidence no longer justifies regulating these exposures.
This 'doubt science' strategy is further enabled by industry's long-standing refusal to test many of its own PFAS compounds—of which there are more than 12,000, only a fraction of which have been tested —creating large evidence gaps. The administration can claim that regulation is premature until more 'gold standard' research is conducted. But who will conduct that research? Industry has little incentive to investigate the risks of its own products, and the Trump administration has shown no interest in requiring it to do so. Furthermore, the government controls the flow of federal research funding and can restrict public science at its source. In fact, the EPA under Trump has already canceled millions of dollars in PFAS research, asserting that the work is 'no longer consistent with EPA funding priorities.'
In a broader context, the 'gold standard' executive order is just one part of the administration's larger effort to weaken the nation's scientific infrastructure. Rather than restore 'the scientific enterprise and institutions that create and apply scientific knowledge in service of the public good,' as the executive order promises, Elon Musk and his DOGE crew fired hundreds, if not thousands, of career scientists and abruptly terminated billions of dollars of ongoing research. To ensure that federal research support remains low, Trump's recently proposed budget slashes the research budgets of virtually every government research agency, including the National Science Foundation, the National Institutes of Health, and the EPA.
Following the hollowing-out of the nation's scientific infrastructure through deep funding cuts and the firing of federal scientists, the executive order is an attempt to rewrite the rules of how our expert bureaucracy operates. It marks a fundamental shift: The already weakened expert agencies will no longer be tasked with producing scientific findings that are reliable by professional standards and insulated from political pressure. Instead, political officials get to intervene at any point to elevate studies that support their agenda and, when necessary, are able to direct agency staff—under threat of insubordination—to scour the record for every conceivable uncertainty or point of disagreement. The result is a system in which science, rather than informing policy, is shaped to serve it.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US, China to launch new talks on tariff truce extension, easing path for Trump-Xi meeting
US, China to launch new talks on tariff truce extension, easing path for Trump-Xi meeting

Yahoo

time24 minutes ago

  • Yahoo

US, China to launch new talks on tariff truce extension, easing path for Trump-Xi meeting

By David Lawder STOCKHOLM (Reuters) -Top U.S. and Chinese economic officials will resume talks in Stockholm on Monday to try to tackle longstanding economic disputes at the centre of a trade war between the world's top two economies, aiming to extend a truce by three months and keeping sharply higher tariffs at bay. China is facing an August 12 deadline to reach a durable tariff agreement with President Donald Trump's administration, after Beijing and Washington reached preliminary deals in May and June to end weeks of escalating tit-for-tat tariffs and a cut-off of rare earth minerals. Without an agreement, global supply chains could face renewed turmoil from U.S. duties snapping back to triple-digit levels that would amount to a bilateral trade embargo. The Stockholm talks come hot on the heels of Trump's biggest trade deal yet with the European Union on Sunday for a 15% tariff on most EU goods exports to the U.S., including autos. The bloc will also buy $750 billion worth of American energy and make $600 billion worth of U.S. investments in coming years. No similar breakthrough is expected in the U.S.-China talks but trade analysts said that another 90-day extension of a tariff and export control truce struck in mid-May was likely. An extension of that length would prevent further escalation and facilitate planning for a potential meeting between Trump and Chinese President Xi Jinping in late October or early November. A U.S. Treasury spokesperson declined comment on a South China Morning Post report quoting unnamed sources as saying the two sides would refrain from introducing new tariffs or other steps that could escalate the trade war for another 90 days. Trump's administration is poised to impose new sectoral tariffs that will impact China within weeks, including on semiconductors, pharmaceuticals, ship-to-shore cranes and other products. "We're very close to a deal with China. We really sort of made a deal with China, but we'll see how that goes," Trump told reporters on Sunday before European Commission President Ursula von der Leyen struck their tariff deal. DEEPER ISSUES Previous U.S.-China trade talks in Geneva and London in May and June focused on bringing U.S. and Chinese retaliatory tariffs down from triple-digit levels and restoring the flow of rare earth minerals halted by China and Nvidia's H20 AI chips and other goods halted by the United States. So far, the talks have not delved into broader economic issues. They include U.S. complaints that China's state-led, export-driven model is flooding world markets with cheap goods, and Beijing's complaints that U.S. national security export controls on tech goods seek to stunt Chinese growth. "Geneva and London were really just about trying to get the relationship back on track so that they could, at some point, actually negotiate about the issues which animate the disagreement between the countries in the first place," said Scott Kennedy, a China economics expert at the Center for Strategic and International Studies in Washington. "I'd be surprised if there is an early harvest on some of these things but an extension of the ceasefire for another 90 days seems to be the most likely outcome," Kennedy said. U.S. Treasury Secretary Scott Bessent has already flagged a deadline extension and has said he wants China to rebalance its economy away from exports to more domestic consumption -- a decades-long goal for U.S. policymakers. Analysts say the U.S.-China negotiations are far more complex than those with other Asian countries and will require more time. China's grip on the global market for rare earth minerals and magnets, used in everything from military hardware to car windshield wiper motors, has proved to be an effective leverage point on U.S. industries. TRUMP-XI MEETING? In the background of the talks is speculation about a possible meeting between Trump and Xi in late October. Trump has said he will decide soon on a landmark trip to China, and a new flare-up of tariffs and export controls would likely derail planning. Sun Chenghao, a fellow at Tsinghua University's Center for International Security and Strategy in Beijing, said that a Trump-Xi summit would be an opportunity for the U.S. to lower the 20% tariffs on Chinese goods related to fentanyl. In exchange, he said the Chinese side could make good on its 2020 pledge to increase purchases of U.S. farm products and other goods. "The future prospect of the heads of state summit is very beneficial to the negotiations because everyone wants to reach an agreement or pave the way in advance," Sun said. Still, China will likely request a reduction of multi-layered U.S. tariffs totaling 55% on most goods and further easing of U.S. high-tech export controls, analysts said. Beijing has argued that such purchases would help reduce the U.S. trade deficit with China, which reached $295.5 billion in 2024.

Hong Kong's CK Hutchison seeks Chinese investor to join Panama Ports deal
Hong Kong's CK Hutchison seeks Chinese investor to join Panama Ports deal

San Francisco Chronicle​

time25 minutes ago

  • San Francisco Chronicle​

Hong Kong's CK Hutchison seeks Chinese investor to join Panama Ports deal

HONG KONG (AP) — A Hong Kong conglomerate that's selling ports at the Panama Canal said Monday it may seek a Chinese investor to join a consortium of buyers, a move that could please Beijing but bring more U.S. scrutiny to the geopolitically fraught deal. CK Hutchison Holdings' initial plan to sell port assets in dozens of countries to a group that includes U.S. investment firm BlackRock Inc. pleased President Donald Trump, who has alleged that China interferes with the critical shipping lane's operations in Panama. However, they apparently angered Beijing and drew a review from Chinese anti-monopoly authorities. A Hutchison subsidiary has operated ports at both ends of the Panama Canal since 1997. After months of uncertainty brought by tensions between Washington and Beijing, Hutchison said in a statement that the exclusive negotiations period with the consortium has expired. However, it added 'the Group remains in discussions with members of the consortium with a view to inviting major strategic investor from the PRC to join as a significant member of the consortium,' referring to the People's Republic of China. It said they needed to change the membership of the consortium and the structure of the transaction for the deal to be able to pass reviews by 'all relevant authorities." The awkward position Hutchison found itself in for months highlights the challenges Hong Kong business elites face in navigating Beijing's expectations of national loyalty, especially when relations between China and the United States are strained. Hong Kong has overhauled its electoral system to ensure the city is run by 'patriots.' CK Hutchison is owned by the family of Hong Kong's richest man, Li Ka-shing. It announced March 4 that it would sell all its shares in Hutchison Port Holdings and in Hutchison Port Group Holdings to the consortium that also includes BlackRock subsidiary Global Infrastructure Partners and Terminal Investment Limited, a subsidiary of the Mediterranean Shipping Company. In May, Hutchinson co-managing director, Dominic Lai told shareholders that Terminal Investment was the main investor. Its parent company is led by Italian shipping scion Diego Aponte, whose family reportedly has a longstanding relationship with Li's. The initial deal, valued at nearly $23 billion including $5 billion in debt, would have given the consortium control over 43 ports in 23 countries, including the ports of Balboa and Cristobal, located at either end of the canal. That agreement also required approval from Panama's government.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store